MTOR and graft versus host disease: The aim of our real-life analysis was twofold: first, to assess the effect on transplant outcomes of combining PTCy with calcineurin inhibitor + MMF, rather than mTOR inhibitor + MMF, for GvHD prophylaxis; and second, to evaluate the effect of stratification by conditioning intensity in the setting of haplo-HCT.